Known as the "Triple Agonist," it is the most potent weight management peptide currently in development. By targeting three different hunger and fat-burning pathways (GLP-1, GIP, and Glucagon), it has shown weight loss results exceeding 24% of total body weight in clinical trials, outperforming almost everything else on the market.
